Clinical and Molecular Portraits of Pediatric RASopathies : A Study of 118 Genotype‐Confirmed Cases
Clinical Genetics · 2026-09 · 110 (3) · 299-314
DOI: 10.1111/cge.70193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 09.06.2026. Verfasst von Aslı Genç und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Genetics, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Noonan Syndrome, ras Proteins. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
RASopathies are clinically and genetically heterogeneous disorders resulting from dysregulation of the RAS/MAPK pathway. We present a single‐center retrospective cohort of 118 genotype‐confirmed pediatric patients diagnosed with RASopathy. Noonan syndrome was the most common clinical diagnosis, followed by NF‐Noonan syndrome, Legius syndrome, LEOPARD syndrome, Costello syndrome, and cardiofaciocutaneous syndrome. The most frequent clinical features included short stature, pulmonary stenosis, pectus deformities, and neurocognitive delay. Through molecular analysis, we identified distinct variants across major RAS/MAPK pathway genes, with a considerable proportion of patients carrying rare or less frequently reported variants, including those in LZTR1, RIT1, RAF1, HRAS, BRAF, RASA2, KRAS, CBL, SHOC2, and MAP2K2 . In addition to well‐established genotype–phenotype correlations, we report several uncommon or previously unrecognized features: microcephaly in multiple PTPN11 ‐positive patients and renal agenesis in a child with a novel HRAS variant diagnosed with Costello syndrome. Furthermore, we identified three patients harboring RASA2 variants, providing additional support for its emerging role in Noonan syndrome. This study expands the clinical and molecular spectrum of pediatric RASopathies. It emphasizes the need for comprehensive genetic evaluation and regular follow‐up in the context of overlapping clinical features, supporting accurate diagnosis and identifying candidates for emerging targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Genetics, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey.
- Department of Pediatrics, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey.
- Faculty of Medicine, Department of Medical Genetics, Ankara Yıldırım Beyazit University, Ankara, Turkey.
- Department of Medical Genetics, Ankara Bilkent City Hospital, Ankara, Turkey.
- Department of Pediatric Cardiology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey.
- Department of Pediatric Cardiology, Başkent University Ankara Hospital, Ankara, Turkey.
ORCID-Profile: Aslı Genç, Büşranur Çavdarlı, Esra Kılıç
Zitieren
APA
Genç, A., Sarıkaya, E., Ceylan, A. C., Çavdarlı, B., Çetin, İ. İ., Erdoğan, İ., & Kılıç, E. (2026). Clinical and Molecular Portraits of Pediatric RASopathies : A Study of 118 Genotype‐Confirmed Cases. Clinical Genetics, 110(3), 299-314. https://doi.org/10.1111/cge.70193
Vancouver
Genç A, Sarıkaya E, Ceylan AC, Çavdarlı B, Çetin İİ, Erdoğan İ, et al. Clinical and Molecular Portraits of Pediatric RASopathies : A Study of 118 Genotype‐Confirmed Cases. Clinical Genetics. 2026;110(3):299-314. doi:10.1111/cge.70193
BibTeX
@article{Gen2026,
author = {Genç, Aslı and Sarıkaya, Elif and Ceylan, Ahmet Cevdet and Çavdarlı, Büşranur and Çetin, İbrahim İlker and Erdoğan, İlkay and Kılıç, Esra},
title = {Clinical and Molecular Portraits of Pediatric RASopathies : A Study of 118 Genotype‐Confirmed Cases},
journal = {Clinical Genetics},
year = {2026},
volume = {110},
number = {3},
pages = {299--314},
doi = {10.1111/cge.70193}
}
EUVIMED